TRAF6 and myocardial ischemia: DHC (266) was observed to alleviate myocardial ischemia/reperfusion damage by suppressing apoptosis, inflammation, and oxidative stress through the inhibition of the TNF receptor-associated factor 6 (TRAF6)/NF-κB signaling pathway [102].